EUCTR2007-007638-21-GB进行中（未招募）1 期
Is cessation of clopidogrel therapy associated with rebound of platelet activity in stable vascular disease patients? - CLASP/platelet rebound after clopidogrel
niversity of Aberdeen0 个研究点目标入组 172 人开始时间: 2008年7月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients aged between 30-80 yrs with evidence of chronic atherosclerotic disease - stable coronary heart disease or peripheral arterial disease. All subjects will already be receiving standard secondary preventive therapy including aspirin therapy and a statin.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients will be excluded if they have a known allergy to clopidogrel, have a history of thrombocytopenia, neutropenia, haematological malignancy, abnormal renal or hepatic function, transfusion of whole blood cells within 14 days prior to randomisation, known or suspected drug or alcohol abuse, bleeding diathesis, or clinical symptoms of heart failure. Women of child-bearing potential will be excluded. Patients taking other antiplatelet drugs other than aspirin, or taking anticoagulant drugs will be excluded.
- •Concurrent use of proton pump inhibitors (amendment AM005 November 2009).
研究者
相似试验
已完成
不适用
Is cessation of clopidogrel therapy associated with rebound of platelet activity in stable vascular disease patients?Cardiovascular and peripheral vascular diseaseCirculatory SystemAtherosclerosisISRCTN77887299Grampian Health Board and University of Aberdeen (UK)156
进行中（未招募）
1 期
Is intensive blood thinning with three antiplatelet drugs better than the current guideline treatment in reducing recurrence after acute stroke?EUCTR2007-006749-42-DKniversity of Nottingham4,100
进行中（未招募）
1 期
Is intensive blood thinning with three antiplatelet drugs better than the current guideline treatment in reducing recurrence after acute stroke?Ischaemic stroke and TIA (transient ischaemic attack)MedDRA version: 14.1 Level: LLT Classification code 10042244 Term: Stroke System Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1 Level: PT Classification code 10044390 Term: Transient ischaemic attack System Organ Class: 10029205 - Nervous system disordersEUCTR2007-006749-42-GBniversity of Nottingham3,096
尚未招募
4 期
Does the dual antiplatelet medication of aspirin and either clopidogrel or prasugrel affect inflammatory and oxidative stress measures in individuals with acute coronary syndrome similarly?CTRI/2023/07/055349Pt B D Sharma PGIMS Rohtak
进行中（未招募）
1 期
Pilot Study related to the effect of clopidogrel on plasmatic soluble CD40 ligand during systemic lupus erythematoussystemic lupus erythematousEUCTR2014-003733-25-FRCHU de BORDEAUX30